Cubist Systematic Strategies’s 908 Devices MASS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$420K Buy
+47,934
New +$319K ﹤0.01% 2357
2024
Q4
Sell
-10,710
Closed -$37.2K 3321
2024
Q3
$37.2K Sell
10,710
-49,719
-82% -$221K ﹤0.01% 2781
2024
Q2
$311K Buy
+60,429
New +$365K ﹤0.01% 2337
2023
Q2
Sell
-34,592
Closed -$297K 3974
2023
Q1
$297K Buy
34,592
+12,373
+56% +$110K ﹤0.01% 3002
2022
Q4
$169K Sell
22,219
-29,593
-57% -$358K ﹤0.01% 3659
2022
Q3
$852K Buy
+51,812
New +$1.01M ﹤0.01% 2753
2022
Q2
Sell
-20,364
Closed -$387K 4465
2022
Q1
$387K Buy
20,364
+9,510
+88% +$163K ﹤0.01% 2686
2021
Q4
$281K Buy
+10,854
New +$319K ﹤0.01% 2841
2021
Q2
Sell
-7,664
Closed -$372K 3016
2021
Q1
$372K Buy
+7,664
New +$438K ﹤0.01% 2130

Other funds holding MASS

Cubist Systematic Strategies's MASS Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in 908 Devices (MASS) in Q3 2025: 47,934 shares worth $420K. The stake represents ﹤0.01% of the portfolio and ranks #2357 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in MASS as recently as Q3 2024.

Cubist Systematic Strategies first reported a position in MASS in Q1 2021 and has held it in 9 quarters since. The position peaked at $852K in Q3 2022. 107 funds tracked by Wall St. Rank hold MASS as of Q3 2025.

  • Cubist Systematic Strategies held 47,934 shares of 908 Devices worth $420K as of Q3 2025.
  • 908 Devices was a new Cubist Systematic Strategies position in Q3 2025.
  • 908 Devices made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2357 holding.
  • Cubist Systematic Strategies first reported a position in 908 Devices in Q1 2021 and has held it in 9 quarters since.
  • Cubist Systematic Strategies's 908 Devices position peaked at $852K in Q3 2022.
  • 107 funds tracked by Wall St. Rank held 908 Devices as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.